Oral Anti-Amyloid Shows Disease-Modifying Potential ...Middle East

Medscape - News
Use of ALZ-801, an optimized prodrug of tramiprosate, led to a significant reduction of plasma p-tau181, slowing of hippocampal atrophy, and stabilization of cognition in a phase 2 trial. Medscape Medical News

Hence then, the article about oral anti amyloid shows disease modifying potential was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Oral Anti-Amyloid Shows Disease-Modifying Potential )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News